You are here:
Publication details
Tyrosine-kinase inhibitors (TKI) in first-line treatment of 470 patients with non-small cell lung cancer (NSCLC) from the Czech Republic
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Conference abstract |
| Citation |